Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Published March 2, 2022 · Recall initiated: February 7, 2022
Summary
FDA records drug Class II recall D-0573-2022, published March 2, 2022 and initiated February 7, 2022. Recalling firm: RISING PHARMACEUTICALS; Status: Ongoing; Reported quantity: 2220 100-count bottles; Lot: lot# 25910009, Exp 01/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPHENIDATE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPHENIDATE HYDROCHLORIDE
- Manufacturer
- RISING PHARMACEUTICALS
- Distributor
- Nationwide in the USA
- Lot
- lot# 25910009, Exp 01/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, ManufacturedJuly 10, 2024
- FDAMethylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: OhmAugust 2, 2023
- FDAPrevantics (chlorhexidine gluconate and isopropyl alcohol) Swabstick, 3.15% w/v and 70% v/v, packaged as a)March 2, 2022
- FDALung Cleaner (saline eucalyptus) inhaler, 37 oz cans, Manufactured For: The Lung Cleaner LLC Boulder, CO 80302March 2, 2022
- FDAMethylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, TevaFebruary 19, 2020
- FDAMethylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, TevaFebruary 19, 2020
Questions about this recall
Was Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01 recalled?
Yes. FDA published recall D-0573-2022 on March 2, 2022. Reported hazard: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPHENIDATE HYDROCHLORIDE.